0 515

Cited 12 times in

Clinical Indication of Aspirin Associated With Reduced Risk of Liver Cancer in Chronic Hepatitis B: A Nationwide Cohort Study

DC Field Value Language
dc.contributor.author김범경-
dc.contributor.author안상훈-
dc.contributor.author윤병윤-
dc.contributor.author윤진하-
dc.date.accessioned2022-07-08T03:15:10Z-
dc.date.available2022-07-08T03:15:10Z-
dc.date.issued2022-05-
dc.identifier.issn0002-9270-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/188744-
dc.description.abstractIntroduction: Despite the overall association of aspirin on reduced hepatocellular carcinoma (HCC) risk, there have been few studies on its benefit according to specific clinical conditions among hepatitis B virus (HBV)-infected patients. This study aimed to identify subgroups which benefit from long-term aspirin use. Methods: Nationwide data covering the HBV-infected population in the Republic of Korea from 2010 to 2011 were analyzed. Patients who had been taking Aspirin for ≥3 years were classified as aspirin users. The primary outcome was HCC development. The multivariable Fine and Gray competing risk regression model was used to estimate the adjusted hazard ratio (HR) in the entire cohort. Propensity score matching at a 1:4 ratio was also performed. Results: Among 161,673 patients, 7,083 newly developed HCC during follow-up (mean: 7.5 years). After adjusting for age, sex, hypertension, diabetes mellitus, dyslipidemia, cirrhosis, antivirals, metformin, statin, smoking, alcohol consumption, and obesity, aspirin users (n = 9,837) were less likely to develop HCC; the adjusted HR was 0.84 (P = 0.002) in the entire cohort and 0.87 (P = 0.010) in the matched cohort. Association of aspirin use with all-cause mortality was not significant (HR = 0.93; P = 0.192), whereas association with liver-related mortality was significant (HR = 0.79; P = 0.019). A significant association was observed in the subgroups with cirrhosis, both sexes, hypertension, non-diabetes mellitus, nonantivirals against chronic hepatitis B, nonmetformin use, nonstatin use, both smoking histories, and obesity (all P < 0.05). Discussion: Long-term aspirin use is significantly associated with reduced risk of HCC in chronic HBV patients. More comprehensive studies should be implemented to clarify the causal relationship.-
dc.description.statementOfResponsibilityrestriction-
dc.languageEnglish-
dc.publisherNature Pub. Group-
dc.relation.isPartOfAMERICAN JOURNAL OF GASTROENTEROLOGY-
dc.rightsCC BY-NC-ND 2.0 KR-
dc.subject.MESHAspirin / therapeutic use-
dc.subject.MESHCarcinoma, Hepatocellular* / epidemiology-
dc.subject.MESHCarcinoma, Hepatocellular* / etiology-
dc.subject.MESHCarcinoma, Hepatocellular* / prevention & control-
dc.subject.MESHCohort Studies-
dc.subject.MESHFemale-
dc.subject.MESHHepatitis B virus-
dc.subject.MESHHepatitis B, Chronic* / complications-
dc.subject.MESHHepatitis B, Chronic* / drug therapy-
dc.subject.MESHHepatitis B, Chronic* / epidemiology-
dc.subject.MESHHumans-
dc.subject.MESHHypertension*-
dc.subject.MESHIncidence-
dc.subject.MESHLiver Cirrhosis / complications-
dc.subject.MESHLiver Neoplasms* / epidemiology-
dc.subject.MESHLiver Neoplasms* / etiology-
dc.subject.MESHLiver Neoplasms* / prevention & control-
dc.subject.MESHMale-
dc.subject.MESHObesity / complications-
dc.subject.MESHRisk Factors-
dc.titleClinical Indication of Aspirin Associated With Reduced Risk of Liver Cancer in Chronic Hepatitis B: A Nationwide Cohort Study-
dc.typeArticle-
dc.contributor.collegeCollege of Medicine (의과대학)-
dc.contributor.departmentDept. of Internal Medicine (내과학교실)-
dc.contributor.googleauthorByungyoon Yun-
dc.contributor.googleauthorSang Hoon Ahn-
dc.contributor.googleauthorJin-Ha Yoon-
dc.contributor.googleauthorBeom Kyung Kim-
dc.identifier.doi10.14309/ajg.0000000000001725-
dc.contributor.localIdA00487-
dc.contributor.localIdA02226-
dc.contributor.localIdA06231-
dc.contributor.localIdA04616-
dc.relation.journalcodeJ00081-
dc.identifier.eissn1572-0241-
dc.identifier.pmid35294425-
dc.identifier.urlhttps://journals.lww.com/ajg/Fulltext/2022/05000/Clinical_Indication_of_Aspirin_Associated_With.20.aspx-
dc.contributor.alternativeNameKim, Beom Kyung-
dc.contributor.affiliatedAuthor김범경-
dc.contributor.affiliatedAuthor안상훈-
dc.contributor.affiliatedAuthor윤병윤-
dc.contributor.affiliatedAuthor윤진하-
dc.citation.volume117-
dc.citation.number5-
dc.citation.startPage758-
dc.citation.endPage768-
dc.identifier.bibliographicCitationAMERICAN JOURNAL OF GASTROENTEROLOGY, Vol.117(5) : 758-768, 2022-05-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers
1. College of Medicine (의과대학) > Dept. of Preventive Medicine (예방의학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.